MedTech Round Up: Update On Johnson & Johnson, Becton Dickinson, Labcorp, Second Sight Medical, Biocept

  • Designed to be worn overnight, the Acuvue Abiliti orthokeratology lenses are specifically fitted to match each eye, including people with and without astigmatism.
  • Price Action: JNJ shares are trading 1.41% higher at $170.57 during the market session on the last check Thursday.
  • The assay can detect and identify 14 high-risk human papillomavirus (HPV) types in a single analysis and provide genotyping information.
  • Price Action: BDX shares are trading 1.33% higher at $244.85 during the market session on the last check Thursday.
  • The authorization expands the use of Pixel by Labcorp to children and adolescents two years of age and older.
  • Price Action: LH shares are trading 1.97% higher at $277.26 during the market session on the last check Thursday.

Second Sight Medical Products Inc (NASDAQ: EYES) has received year three funding for its Orion Trial from the National Institutes of Health (NIH).

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.